Life sciences distribution is shifting toward AI-powered, resilient networks that improve speed, efficiency, compliance, and ...

On this weeks episode of the Business of Biotech, Simeon George, M.D., Cofounder and CEO at SR One Capital Management, returns to the show to talk about how SR One evaluates biotech investment targets ...

After 30 years of use in transplant medicine, EBV-specific T cells offer key lessons for safer, scalable allogeneic cell therapies, writes Ivan Horak, M.D.

On this weeks episode of the Business of Biotech, Cyriac Roeding talks about cofounding and leading Earli, a "bioAI" company using synthetic DNA switches and cancer-binding lipid nanoparticles to ...

Co-development is an established concept. The practical question is how early its logic should shape candidate selection, development planning, and portfolio governance. Combination therapy is routine ...

Pharmaceutical R&D organizations are built to advance programs. But as a program moves from discovery into clinical development, one question can become surprisingly difficult to ask: “Given what we ...

In pharma, an oncology drug approval is a significant milestone. I have spent enough time in this space to know that it is also the moment where a different, less visible problem begins. The community ...

The choice between Nasdaq and the New York Stock Exchange (or NYSE American) has traditionally been made once – and rarely revisited. Market perception, investor demographics, analyst coverage, ...

In my free time, I’m a pilot. I have my instrument rating, and I just earned my commercial pilot license, not because I plan to fly for the airlines, but because I want to be as good as the men and ...

Over the weekend, the Financial Times reported that AstraZeneca and Bristol Myers Squibb were exploring what would have been the largest pharmaceutical merger in history. The news sent AstraZeneca's ...

For decades, the Silicon Valley playbook has dominated the narrative of innovation: a brilliant founder hacks together a minimum viable product in a garage, pitches a traditional venture capital (VC) ...

Artificial intelligence is increasingly embedded in drug discovery and clinical development, and early data suggests it is beginning to change how quickly companies reach early clinical milestones and ...